ES2078909T3 - Procedimiento para sintetizar agentes hipertropicos prostaticos benignos. - Google Patents

Procedimiento para sintetizar agentes hipertropicos prostaticos benignos.

Info

Publication number
ES2078909T3
ES2078909T3 ES89311066T ES89311066T ES2078909T3 ES 2078909 T3 ES2078909 T3 ES 2078909T3 ES 89311066 T ES89311066 T ES 89311066T ES 89311066 T ES89311066 T ES 89311066T ES 2078909 T3 ES2078909 T3 ES 2078909T3
Authority
ES
Spain
Prior art keywords
formula
hypertropic
synthesize
agents
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89311066T
Other languages
English (en)
Inventor
Apurba Bhattacharya
Ulf H Dolling
Joseph S Amato
John M Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2078909T3 publication Critical patent/ES2078909T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J73/00—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms
    • C07J73/001—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom
    • C07J73/005—Steroids in which the cyclopenta[a]hydrophenanthrene skeleton has been modified by substitution of one or two carbon atoms by hetero atoms by one hetero atom by nitrogen as hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

SE PRESENTAN UN PROCESO PARA PREPARAR COMPUESTOS DE FORMULA (I) QUE COMPRENDEN LA REACCION DE UN IMIDAZORURO DE FORMULA (II) CON UN AMINO DE LA FORMULA NHR4R5 EN LA PRESENCIA DE UN REAGENTE PARA FORMAR UN COMPUESTO DE FORMULA (I) O LA REACCION DE UNA IMIDAZOLA DE LA FORMULA (II) CON UN COMPUESTO DE LA FORMULA R6MGX PARA FORMAR UN COMPUESTO DE LA FORMULA (I).
ES89311066T 1988-10-31 1989-10-26 Procedimiento para sintetizar agentes hipertropicos prostaticos benignos. Expired - Lifetime ES2078909T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/264,652 US5237061A (en) 1988-10-31 1988-10-31 Methods of synthesizing benign prostatic hypertropic agents and their intermediates

Publications (1)

Publication Number Publication Date
ES2078909T3 true ES2078909T3 (es) 1996-01-01

Family

ID=23007023

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89311066T Expired - Lifetime ES2078909T3 (es) 1988-10-31 1989-10-26 Procedimiento para sintetizar agentes hipertropicos prostaticos benignos.

Country Status (11)

Country Link
US (1) US5237061A (es)
EP (1) EP0367502B1 (es)
JP (1) JPH0714959B2 (es)
AT (1) ATE127809T1 (es)
CA (1) CA1326013C (es)
CY (1) CY2078B1 (es)
DE (1) DE68924237T2 (es)
DK (1) DK170734B1 (es)
ES (1) ES2078909T3 (es)
HK (1) HK1002707A1 (es)
IE (1) IE67802B1 (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5061801A (en) * 1990-09-24 1991-10-29 Merck & Co., Inc. Intermediate for making 3-oxo-4-aza-androst-1-ene 17β-ketones
CA2050824A1 (en) * 1990-09-24 1992-03-25 John M. Williams Process for making 3-oxo-4-aza-androst-1-ene 17-.beta.-ketones
US5304562A (en) * 1991-10-09 1994-04-19 Ciba-Geigy Corporation 17β-substituted Aza-androstane derivatives
HU212459B (en) * 1992-10-02 1996-06-28 Richter Gedeon Vegyeszet Process for producing new 17-beta-substituted 4-aza-androstane-derivatives and pharmaceutical compositions containing them
US5468860A (en) † 1992-11-19 1995-11-21 Merck & Co., Inc. New finasteride processes
TW369521B (en) * 1993-09-17 1999-09-11 Smithkline Beecham Corp Androstenone derivative
US5470976A (en) * 1994-09-07 1995-11-28 Merck & Co., Inc. Process for the stereoselective reduction of steroid enelactams
US5541322A (en) * 1994-10-14 1996-07-30 Glaxo Wellcome Inc. Synthesis of 6-azaandrostenones
US5656613A (en) * 1995-01-04 1997-08-12 Merck & Co., Inc. Treatment of hyperandrogenic conditions
GB9727522D0 (en) 1997-12-31 1998-02-25 Pharmacia & Upjohn Spa Process for preparing carboxamido-4-azasteroids
ES2153789B1 (es) * 1999-07-05 2001-10-16 Raga Consultores S L Procedimiento para la obtencion de 178-(n-terc-butlcarbamoil)-3-ona-4-aza-esteroides
US6182013B1 (en) * 1999-07-23 2001-01-30 Schlumberger Technology Corporation Methods and apparatus for dynamically estimating the location of an oil-water interface in a petroleum reservoir
AU2001269911B2 (en) 2000-09-07 2006-09-21 Dr. Reddy's Laboratories Ltd. Novel polymorphic form of 17-beta-(n-ter.butyl carbamoyl)-4-aza-5-alpha-androst-1-en-3-one and a process for preparing it
WO2002020553A1 (en) * 2000-09-07 2002-03-14 Dr. Reddy's Laboratories Ltd. NOVEL POLYMORPHIC FORM OF 17-β-(N-TER.BUTYL CARBAMOYL)-4-AZA-5-α-ANDROST-1-EN-3-ONE AND A PROCESS FOR PREPARING IT
SK2732003A3 (en) * 2000-09-07 2004-01-08 Reddys Lab Ltd Dr Novel polymorphic form of 17-beta-(N-ter.butyl carbamoyl)-4-aza- 5-alpha-androst-1-en-3-one and a process for preparing it
US6645974B2 (en) 2001-07-31 2003-11-11 Merck & Co., Inc. Androgen receptor modulators and methods for use thereof
US7149749B2 (en) * 2002-06-03 2006-12-12 International Business Machines Corporation Method of inserting and deleting leaves in tree table structures
ES2206065B1 (es) 2002-10-31 2005-08-16 Ragactives, S.L. Procedimiento para la obtencion de la forma polimorfica i de finasterida.

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4602099A (en) * 1973-04-02 1986-07-22 Merrell Dow Pharmaceuticals Inc. Antirhinovirus agents
SE7701916L (sv) * 1976-04-27 1977-10-28 Sandoz Ag Organiska foreningar, deras framstellning och anvendning
US4197308A (en) * 1976-11-12 1980-04-08 The Upjohn Company Analgesic N-(2-heterocyclic-amino cycloaliphatic) benzamides
US4377584A (en) * 1978-04-13 1983-03-22 Merck & Co., Inc. 4-Aza-17β-substituted-5α-androstan-3-one-reductase inhibitors
US4179453A (en) * 1978-04-13 1979-12-18 Merck & Co., Inc. Process for preparing 17β-carboxy-5-androsten-3-ones
US4220775A (en) * 1979-03-15 1980-09-02 Merck & Co., Inc. Preparation of 4-aza-17-substituted-5α-androstan-3-ones useful as 5α-reductase inhibitors
US4460509A (en) * 1981-08-19 1984-07-17 Beth Israel Medical Center Chemical synthesis
US4859681A (en) * 1984-02-27 1989-08-22 Merck & Co., Inc. 17 α-Acyl-4-aza-5a-androst-1-en-3-ones as 5 alpha-reductase inhibitors
US4760071A (en) * 1984-02-27 1988-07-26 Merck & Co., Inc. 17β-N-monosubstituted carbamoyl-4-aza-5α-androst-1-en-3-ones which are active as testosterone 5α-reductase inhibitors
NZ211145A (en) * 1984-02-27 1988-10-28 Merck & Co Inc 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions
FR2571727B1 (fr) * 1984-10-16 1987-06-12 Roussel Uclaf Nouveaux produits steroides comportant, en position 23, un radical dihydro oxazolyle, leur procede de preparation, leur application a la preparation de produits de la serie des 20 cetopregnanes et intermediaires de cette application
EP0271219B1 (en) * 1986-11-20 1992-07-29 Merck & Co. Inc. Topical pharmaceutical composition containing 17-beta-methoxycarbonyl-4-methyl-4-aza-5-alpha-androst-1-en-3-one
US4845104A (en) * 1986-11-20 1989-07-04 Merck & Co., Inc. Oxidized analogs of 17β-N-monosubstituted-carbamoyl-4-aza-5-α-androstan-3-ones
NZ225100A (en) * 1987-06-29 1991-09-25 Merck & Co Inc Reaction of steroids (including 4-azasteroids) with a silylating agent in the presence of a quinone to introduce a delta' double bond and silylated intermediates

Also Published As

Publication number Publication date
DK539589A (da) 1990-05-01
DK539589D0 (da) 1989-10-30
DE68924237D1 (de) 1995-10-19
JPH02172999A (ja) 1990-07-04
DE68924237T2 (de) 1996-04-25
IE893483L (en) 1990-04-30
HK1002707A1 (en) 1998-09-11
DK170734B1 (da) 1995-12-27
CA1326013C (en) 1994-01-11
ATE127809T1 (de) 1995-09-15
JPH0714959B2 (ja) 1995-02-22
EP0367502A1 (en) 1990-05-09
CY2078B1 (en) 1998-10-16
IE67802B1 (en) 1996-05-01
EP0367502B1 (en) 1995-09-13
US5237061A (en) 1993-08-17

Similar Documents

Publication Publication Date Title
ES2078909T3 (es) Procedimiento para sintetizar agentes hipertropicos prostaticos benignos.
ES2097583T3 (es) Procedimiento de preparacion de derivados de alcoxiiminoacetamida y un intermediario de este procedimiento.
NO307379B1 (no) 3-merkapto-1-(1,3-tiazolin-2-yl)azetidin-derivater
ES2195510T3 (es) Derivados de imidazopiridina y procedimiento para prepararlos.
ES2113975T3 (es) Azida de tri-alquil superior-estaño y su uso.
DK0452952T3 (da) Fremgangsmåde til fremstilling af benzylaminer
FI873443A (fi) Norfloxacinmellanprodukt.
ES532098A0 (es) Un procedimiento para preparar derivados sustituidos en posicion 1 de azetidin-3-ol
BR9104632A (pt) Composto,composicao farmaceutica,aplicacao do referido composto e processo para a preparacao do referido composto
BR9705662A (pt) Piridinas substituìdas.
IT1197348B (it) Cinnamilammine, processo per la loro preparazione e composizioni farmaceutiche che le contengono
ES2194361T3 (es) Procedimiento y compuestos intermedios para la preparacion de un herbicida de triazol.
NO993154D0 (no) FremgangsmÕte for fremstilling av imidazolderivater
DK359589A (da) Fremgangsmaade til fremstilling af n-substituerede guanylthiourinstoffer
ES2128304T3 (es) Procedimiento para preparar 5-arilhidantoina.
DK0483674T3 (da) Fremgangsmåde til fremstilling af et alifatisk amid og salte deraf
ES2164258T3 (es) Procedimiento de preparacion de derivados de carbamoilmetilurea.
GR3035317T3 (en) Preparation of optically active (S)-(-) and (R)-(+)- deoxyspergualin and novel intermediates thereof
DE69129605T2 (de) Verfahren zur Herstellung von N-Alkylpyrazolen
ATE140217T1 (de) Verfahren zur halognierung von aromatischen verbindungen

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 367502

Country of ref document: ES